Whose Quality of Life? Ethical Implications in Patient-Reported Health Outcome Measurement

Value in Health

Volumn 12, Issue 4, 2009, Pages 613-617

  Hagell, Peter ^a,b   Reimer, Jan ^b   Nyberg, Per ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Clinical research; Ethics; Outcomes research; Parkinson's disease; Quality of life

Indexed keywords

ADULT; AGED; ARTICLE; BIOETHICS; CLINICAL RESEARCH; DISEASE ASSOCIATION; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NOTTINGHAM EXTENDED ACTIVITIES OF DAILY LIVING SCALE; OUTCOMES RESEARCH; PARKINSON DISEASE; PARKINSON DISEASE QUESTIONNAIRE 39; PATIENT REPORTED HEALTH OUTCOME MEASUREMENT; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SHORT FORM 36; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; ETHICS, RESEARCH; FEMALE; HEALTH STATUS; HEALTH SURVEYS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; OUTCOME ASSESSMENT (HEALTH CARE); PARKINSON DISEASE; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; SELF-ASSESSMENT;

EID: 66249143010     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2008.00488.x     Document Type: Article

References (36)

1. Emanuel EJ, Wendler D, Grady C. What makes clinical research ethical? JAMA 2000 283 : 2701 11.
2. Clancy CM, Eisenberg JM. Outcomes research: measuring the end results of health care. Science 1998 282 : 245 6.
3. Fitzpatrick R, Davey C, Buxton MJ, Jones DR. Evaluating patient-based outcome measures for use in clinical trials. Health Technol Assess 1998 2 : 1 74.
4. Food and Drug Administration. Patient-reported outcome measures: use in medicinal product development to support labelling claims. Fed Regist 2006 71 : 5862 3.
5. Carr AJ, Higginson IJ. Are quality of life measures patient centred? BMJ 2001 322 : 1357 60.
6. Doward LC, Meads DM, Thorsen H. Requirements for quality of life instruments in clinical research. Value Health 2004 7 (Suppl. 1 S13 6.
7. Leplege A, Hunt S. The problem of quality of life in medicine. JAMA 1997 278 : 47 50. (Pubitemid 27274516)
8. Hunt SM. The problem of quality of life. Qual Life Res 1997 6 : 205 12.
9. Kirscher KL. Ethical implications of outcomes research. Am J Phys Med Rehabil 2001 80 : 392 9.
10. O'Lonergan TA, Milgrom H. Outcome measures: linking science and ethics in clinical research. Curr Opin Allergy Clin Immunol 2006 6 : 139 43.
11. Sullivan M. The new subjective medicine: taking the patient's point of view on health care and health. Soc Sci Med 2003 56 : 1595 604.
12. Fayers P, Hays R. Assessing Quality of Life in Clinical Trials: Methods and Practice (2nd ed.). New York : Oxford University Press, 2005.
13. Hagell P, Törnqvist AL, Hobart J. Testing the SF-36 in Parkinson's disease: implications for reporting rating scale data. J Neurol 2008 255 : 246 54.
14. The European Group for Quality of Life Assessment and Health Measurement. European Guide to the Nottingham Health Profile. Brookwood, Surrey : Brookwood Medical Publications, 1993.
15. McKenna SP, Hunt SM, Tennant A. The development of a patient-completed index of distress from the Nottingham Health Profile: a new measure for use in cost-utility studies. Br J Med Econ 1993 6 : 13 24. (Pubitemid 24078254)
16. Ware JE Jr., Gandek M, Kosinski B. SF-36 Health Survey: Manual and Interpretation Guide. Lincoln, RI : QualityMetric Incorporated, 1993, 2000.
17. Peto V, Jenkinson C, Fitzpatrick R, Greenhall R. The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. Qual Life Res 1995 4 : 241 8.
18. Hagell P, Whalley D, McKenna SP, Lindvall O. Health status measurement in Parkinson's disease: validity of the PDQ-39 and Nottingham Health Profile. Mov Disord 2003 18 : 773 83.
19. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967 17 : 427 42.
20. Dallmeijer AJ, Dekker J, Knol DL, et al. Dimensional structure of the SF-36 in neurological patients. J Clin Epidemiol 2006 59 : 541 3.
21. Jenkinson C, Heffernan C, Doll H, Fitzpatrick R. The Parkinson's Disease Questionnaire (PDQ-39): evidence for a method of imputing missing data. Age Ageing 2006 35 : 497 502. (Pubitemid 44295638)
22. McHorney CA, Ware JE Jr., Lu JF, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994 32 : 40 66.
23. Moore F, Wolfson C, Alexandrov L, Lapierre Y. Do general and multiple sclerosis-specific quality of life instruments differ? Can J Neurol Sci 2004 31 : 64 71. (Pubitemid 38325761)
24. Doward LC, McKenna SP. Defining patient-reported outcomes. Value Health 2004 7 (Suppl. 1 S4 8.
25. Brodersen J, McKenna SP, Doward LC, Thorsen H. Measuring the psychosocial consequences of screening. Health Qual Life Outcomes 2007 5 : 3.
26. Hagell P, McKenna SP. International use of health status questionnaires in Parkinson's disease: translation is not enough. Parkinsonism Relat Disord 2003 10 : 89 92. (Pubitemid 37476312)
27. Kim MY, Dahlberg A, Hagell P. Respondent burden and patient-perceived validity of the PDQ-39. Acta Neurol Scand 2006 113 : 132 7.
28. Paterson C, Allen JA, Browning M, et al. A pilot study of therapeutic massage for people with Parkinson's disease: the added value of user involvement. Complement Ther Clin Pract 2005 11 : 161 71.
29. La Puma J, Lawlor EF. Quality-adjusted life-years. Ethical implications for physicians and policymakers. JAMA 1990 263 : 2917 21.
30. Levine RJ. Quality of life assessments in clinical trials: an ethical perspective. In : Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials (2nd ed.). Philadelphia : Lippincott Raven Publishers, 1996.
31. Lee MA, Walker RW, Hildreth AJ, Prentice WM. Individualized assessment of quality of life in idiopathic Parkinson's disease. Mov Disord 2006 21 : 1929 34.
32. Neudert C, Wasner M, Borasio GD. Patients' assessment of quality of life instruments: a randomised study of SIP, SF-36 and SEIQoL-DW in patients with amyotrophic lateral sclerosis. J Neurol Sci 2001 191 : 103 9.
33. Hill S, Harries U, Popay J. Is the short form 36 (SF-36) suitable for routine health outcomes assessment in health care for older people? Evidence from preliminary work in community based health services in England. J Epidemiol Community Health 1996 50 : 94 8.
34. The Global Parkinson's Disease Survey (GPDS) Steering Committee. Factors impacting on quality of life in Parkinson's disease: results from an international survey. Mov Disord 2002 17 : 60 7.
35. Bernhard J, Sullivan M, Hurny C, et al. Clinical relevance of single item quality of life indicators in cancer clinical trials. Br J Cancer 2001 84 : 1156 65.
36. Sullivan M, Karlsson J, Ware JE Jr. The Swedish SF-36 Health Survey - I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden. Soc Sci Med 1995 41 : 1349 58.